A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system

Related articles

1. Pharmacovigilance Analysis of Vinorelbine: Cardiopulmonary and Pediatric Safety Profiles Based on FAERS and VigiBase Data

   This article has 5 authors:

   1. Ye Zhang
   2. Mengnan Shuai
   3. Dan Huang
   4. Minghua Yang
   5. Shengfeng Wang

2. Gastrointestinal and Skin Safety Evaluation of Pirfenidone versus Nintedanib: An Analysis of Real-World Pharmacovigilance and Randomized Controlled Trials

   This article has 7 authors:

   1. Yang Xinping
   2. Yuting Wang
   3. Xijier Qiaolongbatu
   4. Han Qu
   5. Zhiying Li
   6. Jiaqi Wu
   7. Zhenghua Wu

3. Drug-Related Rhabdomyolysis: A Real-World FDA Adverse Event Reporting System Database Study

   This article has 4 authors:

   1. Jialu Hu
   2. Yiqing Sun
   3. Xutao Ma
   4. Huanru Qu